Literature DB >> 19592611

Absence of gp130 in dopamine beta-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias.

Diana C Parrish1, Eric N Alston, Hermann Rohrer, Sam M Hermes, Sue A Aicher, Paul Nkadi, William R Woodward, Jutta Stubbusch, Ryan T Gardner, Beth A Habecker.   

Abstract

Inflammatory cytokines that act through glycoprotein (gp)130 are elevated in the heart after myocardial infarction and in heart failure. These cytokines are potent regulators of neurotransmitter and neuropeptide production in sympathetic neurons but are also important for the survival of cardiac myocytes after damage to the heart. To examine the effect of gp130 cytokines on cardiac nerves, we used gp130(DBH-Cre/lox) mice, which have a selective deletion of the gp130 cytokine receptor in neurons expressing dopamine beta-hydroxylase (DBH). Basal sympathetic parameters, including norepinephrine (NE) content, tyrosine hydroxylase expression, NE transporter expression, and sympathetic innervation density, appeared normal in gp130(DBH-Cre/lox) compared with wild-type mice. Likewise, basal cardiovascular parameters measured under isoflurane anesthesia were similar in both genotypes, including mean arterial pressure, left ventricular peak systolic pressure, dP/dt(max), and dP/dt(min). However, pharmacological interventions revealed an autonomic imbalance in gp130(DBH-Cre/lox) mice that was correlated with an increased incidence of premature ventricular complexes after reperfusion. Stimulation of NE release with tyramine and infusion of the beta-agonist dobutamine revealed blunted adrenergic transmission that correlated with decreased beta-receptor expression in gp130(DBH-Cre/lox) hearts. Due to the developmental expression of the DBH-Cre transgene in parasympathetic ganglia, gp130 was eliminated. Cholinergic transmission was impaired in gp130(DBH-Cre/lox) hearts due to decreased parasympathetic drive, but tyrosine hydroxylase immunohistochemistry in the brain stem revealed that catecholaminergic nuclei appeared grossly normal. Thus, the apparently normal basal parameters in gp130(DBH-Cre/lox) mice mask an autonomic imbalance that includes alterations in sympathetic and parasympathetic transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592611      PMCID: PMC2755986          DOI: 10.1152/ajpheart.00409.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

Review 1.  Central mechanisms underlying short- and long-term regulation of the cardiovascular system.

Authors:  R A L Dampney; M J Coleman; M A P Fontes; Y Hirooka; J Horiuchi; Y W Li; J W Polson; P D Potts; T Tagawa
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

2.  Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction.

Authors:  Maria Teresa La Rovere; Chiara Bersano; Marco Gnemmi; Giuseppe Specchia; Peter J Schwartz
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

Review 3.  Expert consensus document on beta-adrenergic receptor blockers.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

4.  Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation.

Authors:  B K Brar; A Stephanou; Z Liao; R M O'Leary; D Pennica; D M Yellon; D S Latchman
Journal:  Cardiovasc Res       Date:  2001-08-01       Impact factor: 10.787

Review 5.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

Review 6.  Antiarrhythmic properties of beta-blockers.

Authors:  W Haverkamp; G Hindricks; H Gülker
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

7.  Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat.

Authors:  T Aoyama; Y Takimoto; D Pennica; R Inoue; E Shinoda; R Hattori; Y Yui; S Sasayama
Journal:  J Mol Cell Cardiol       Date:  2000-10       Impact factor: 5.000

8.  Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction.

Authors:  Yunzeng Zou; Hiroyuki Takano; Miho Mizukami; Hiroshi Akazawa; Yingjie Qin; Haruhiro Toko; Masaya Sakamoto; Tohru Minamino; Toshio Nagai; Issei Komuro
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

9.  Regulation of noradrenergic function by inflammatory cytokines and depolarization.

Authors:  Wei Li; David Knowlton; William R Woodward; Beth A Habecker
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

10.  Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons.

Authors:  Wei Li; David Knowlton; Donna M Van Winkle; Beth A Habecker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-15       Impact factor: 4.733

View more
  11 in total

1.  STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration.

Authors:  Michael J Pellegrino; Beth A Habecker
Journal:  Mol Cell Neurosci       Date:  2013-07-03       Impact factor: 4.314

2.  Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves.

Authors:  Diana C Parrish; Eric N Alston; Hermann Rohrer; Paul Nkadi; William R Woodward; Günther Schütz; Beth A Habecker
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

3.  Ciliary neurotrophic factor stimulates tyrosine hydroxylase activity.

Authors:  Xiao Shi; William R Woodward; Beth A Habecker
Journal:  J Neurochem       Date:  2012-04-12       Impact factor: 5.372

4.  Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor.

Authors:  Christina U Lorentz; Diana C Parrish; Eric N Alston; Michael J Pellegrino; William R Woodward; Barbara L Hempstead; Beth A Habecker
Journal:  Exp Neurol       Date:  2013-09-03       Impact factor: 5.330

5.  Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias.

Authors:  Belinda H McCully; Wohaib Hasan; Cole T Streiff; Jennifer C Houle; William R Woodward; George D Giraud; Virginia L Brooks; Beth A Habecker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

6.  Altered norepinephrine content and ventricular function in p75NTR-/- mice after myocardial infarction.

Authors:  Christina U Lorentz; William R Woodward; Kevin Tharp; Beth A Habecker
Journal:  Auton Neurosci       Date:  2011-06-08       Impact factor: 3.145

7.  Altered atrial neurotransmitter release in transgenic p75(-/-) and gp130 KO mice.

Authors:  Wohaib Hasan; William R Woodward; Beth A Habecker
Journal:  Neurosci Lett       Date:  2012-09-19       Impact factor: 3.046

Review 8.  The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction.

Authors:  Samantha D Francis Stuart; Nicole M De Jesus; Merry L Lindsey; Crystal M Ripplinger
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

9.  Myocardial Infarction Causes Transient Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via gp130.

Authors:  Antoinette Olivas; Ryan T Gardner; Lianguo Wang; Crystal M Ripplinger; William R Woodward; Beth A Habecker
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

10.  Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction.

Authors:  Hesheng Hu; Yongli Xuan; Mei Xue; Wenjuan Cheng; Ye Wang; Xinran Li; Jie Yin; Xiaolu Li; Na Yang; Yugen Shi; Suhua Yan
Journal:  BMC Cardiovasc Disord       Date:  2016-01-19       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.